Illumina logo

Illumina

DNA sequencing and array-based technologies for research, clinical and applied markets.

ShareLink copied

The record

Vertical
Genomics
Headquarters
San Diego
Ticker
NASDAQ: ILMN

What they do

Illumina is a San Diego genomics company focused on DNA sequencing and array-based technologies for research, clinical and applied markets. It trades on NASDAQ under ILMN. Rami Mehio is senior vice president and general manager of its BioInsight business. Kyle Farh, MD, PhD, vice president of artificial intelligence, runs the BioInsight AI Lab.

History and progression

How Illumina got here, step by step.

  1. 19 November 2026

    Virtual Cell Challenge win

    Announced that its BioInsight AI Lab won the 2026 Virtual Cell Challenge, hosted by Arc Institute, among roughly 1,500 competitors. Its new CellularAI algorithm was trained on the Illumina Billion Cell Atlas, a genome-wide CRISPR perturbation dataset across more than 200 disease-relevant cell lines generated in a consortium with select pharmaceutical partners. An open-source initial version of CellularAI was released the same day.

Recent news

  1. 19 November 2026

    Virtual Cell Challenge win

Your daily HealthTech Signal

No hype. Just signal.

Get the latest HealthTech news, understand why it matters, and see where the industry is headed.

5-minute read Delivered daily Unsubscribe anytime

Read by teams at companies like:

Mayo Clinic logoMayo ClinicCleveland Clinic logoCleveland ClinicJohns Hopkins logoJohns HopkinsKaiser Permanente logoKaiser PermanenteEpic logoEpicPhilips logoPhilipsMedtronic logoMedtronicGE HealthCare logoGE HealthCare